News Image

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Provided By GlobeNewswire

Last update: Mar 4, 2025

Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year

This Appointment Represents the Company’s First Commercial Hire as it Ramps Up Commercial Readiness in Anticipation of FDA Clearance during the Second Quarter of 2025

Read more at globenewswire.com

MICROBOT MEDICAL INC

NASDAQ:MBOT (6/13/2025, 8:19:44 PM)

After market: 2.34 0 (0%)

2.34

-0.14 (-5.65%)



Find more stocks in the Stock Screener

Follow ChartMill for more